866-997-4948(US-Canada Toll Free)

Global Drugs for Herpes Labialis (Oral Herpes) Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 124 Pages

This report studies the global market size of Drugs for Herpes Labialis (Oral Herpes) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Herpes Labialis (Oral Herpes) in these regions.
This research report categorizes the global Drugs for Herpes Labialis (Oral Herpes) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 23 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.

The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.

Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.

North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.

Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

In 2017, the global Drugs for Herpes Labialis (Oral Herpes) market size was 2040 million US$ and is forecast to 3030 million US in 2025, growing at a CAGR of 5.1% from 2018. The objectives of this study are to define, segment, and project the size of the Drugs for Herpes Labialis (Oral Herpes) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Drugs for Herpes Labialis (Oral Herpes) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Drugs for Herpes Labialis (Oral Herpes) include
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Market Size Split by Type
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
Market Size Split by Application
External Use
Oral
Injection

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drugs for Herpes Labialis (Oral Herpes) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Drugs for Herpes Labialis (Oral Herpes) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Herpes Labialis (Oral Herpes) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Herpes Labialis (Oral Herpes) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Drugs for Herpes Labialis (Oral Herpes) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Herpes Labialis (Oral Herpes) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Herpes Labialis (Oral Herpes) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Drugs for Herpes Labialis (Oral Herpes) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type
1.4.2 Aciclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.4.5 Docosanol
1.4.6 Other
1.5 Market by Application
1.5.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application
1.5.2 External Use
1.5.3 Oral
1.5.4 Injection
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size
2.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue 2016-2025
2.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Sales 2016-2025
2.2 Drugs for Herpes Labialis (Oral Herpes) Growth Rate by Regions
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers
3.1.1 Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers
3.1.2 Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturers
3.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers
3.2.1 Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2018)
3.2.2 Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers (2016-2018)
3.3 Drugs for Herpes Labialis (Oral Herpes) Price by Manufacturers
3.4 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Herpes Labialis (Oral Herpes) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Herpes Labialis (Oral Herpes) Product Category
3.4.3 Date of International Manufacturers Enter into Drugs for Herpes Labialis (Oral Herpes) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type
4.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Type
4.3 Drugs for Herpes Labialis (Oral Herpes) Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Application

6 North America
6.1 North America Drugs for Herpes Labialis (Oral Herpes) by Countries
6.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries
6.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drugs for Herpes Labialis (Oral Herpes) by Type
6.3 North America Drugs for Herpes Labialis (Oral Herpes) by Application
6.4 North America Drugs for Herpes Labialis (Oral Herpes) by Company

7 Europe
7.1 Europe Drugs for Herpes Labialis (Oral Herpes) by Countries
7.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries
7.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Herpes Labialis (Oral Herpes) by Type
7.3 Europe Drugs for Herpes Labialis (Oral Herpes) by Application
7.4 Europe Drugs for Herpes Labialis (Oral Herpes) by Company

8 Asia Pacific
8.1 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) by Countries
8.1.1 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries
8.1.2 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) by Type
8.3 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) by Application
8.4 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) by Company

9 Central & South America
9.1 Central & South America Drugs for Herpes Labialis (Oral Herpes) by Countries
9.1.1 Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries
9.1.2 Central & South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drugs for Herpes Labialis (Oral Herpes) by Type
9.3 Central & South America Drugs for Herpes Labialis (Oral Herpes) by Application
9.4 Central & South America Drugs for Herpes Labialis (Oral Herpes) by Company

10 Middle East and Africa
10.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) by Countries
10.1.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries
10.1.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) by Type
10.3 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) by Application
10.4 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) by Company

11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.1.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.1.5 Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.2.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.2.5 Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.3.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.3.5 Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.4.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.4.5 Recent Development
11.5 Cadila
11.5.1 Cadila Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.5.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.5.5 Recent Development
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.6.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.6.5 Recent Development
11.7 Daewoong Pharmaceutical
11.7.1 Daewoong Pharmaceutical Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.7.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.7.5 Recent Development
11.8 Livzon
11.8.1 Livzon Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.8.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.8.5 Recent Development
11.9 Luoxin
11.9.1 Luoxin Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.9.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.9.5 Recent Development
11.10 Med shine
11.10.1 Med shine Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes)
11.10.4 Drugs for Herpes Labialis (Oral Herpes) Product Description
11.10.5 Recent Development
11.11 Bayer (Campho Phenique)
11.12 Blistex
11.13 Kelun Group
11.14 Hikma
11.15 Haiwang
11.16 Carmex
11.17 Cipher

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Drugs for Herpes Labialis (Oral Herpes) Raw Material
13.1.2 Drugs for Herpes Labialis (Oral Herpes) Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Drugs for Herpes Labialis (Oral Herpes)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Production Market Share by Types (Product Category) in 2017
Figure Aciclovir Product Picture
Table Major Manufacturers of Aciclovir
Figure Valacyclovir Product Picture
Table Major Manufacturers of Valacyclovir
Figure Famciclovir Product Picture
Table Major Manufacturers of Famciclovir
Figure Docosanol Product Picture
Table Major Manufacturers of Docosanol
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application 2018-2025 (K Units)
Figure External Use
Figure Oral
Figure Injection
Figure Drugs for Herpes Labialis (Oral Herpes) Report Years Considered
Figure Global Drugs for Herpes Labialis (Oral Herpes) Market Size 2016-2025 (Million US$)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales 2016-2025 (K Units)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions 2016-2025 (K Units)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Regions 2016-2025
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Regions 2016-2025
Figure 2017 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Regions
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions 2016-2025 (Million US$)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions 2016-2025
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions 2016-2025
Figure 2017 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2018) (K Units)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Manufacturers (2016-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Manufacturers in 2017
Table Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2018) (Million US$)
Table Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers (2016-2018)
Figure Drugs for Herpes Labialis (Oral Herpes) Value Share by Manufacturers in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Drugs for Herpes Labialis (Oral Herpes) Price (2016-2018) (USD/Unit)
Table Drugs for Herpes Labialis (Oral Herpes) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drugs for Herpes Labialis (Oral Herpes) Product Category
Table Date of International Manufacturers Enter into Drugs for Herpes Labialis (Oral Herpes) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2016-2025)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2016-2025) (Million US$)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2016-2025)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2016-2025)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type in 2017
Table Drugs for Herpes Labialis (Oral Herpes) Price by Type 2013-2018 (USD/Unit)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2016-2025)
Figure Global Sales Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2025)
Figure Global Sales Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2025)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate 2016-2025 (K Units)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate 2016-2025 (Million US$)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2016-2025) (K Units)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2016-2025)
Figure 2017 North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2016-2025) (Million US$)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries
Figure United States Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure United States Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure 2017 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2025)
Figure 2017 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2018) (K Units)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2017
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate 2016-2025 (K Units)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2016-2025) (K Units)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2016-2025) (Million US$)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (K Units)
Figure France Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure France Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (K Units)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure 2017 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2025)
Figure 2017 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2018) (K Units)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2017
Figure Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries
Figure China Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure India Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure India Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Australia Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Type
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Application
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2018) (K Units)
Table Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2018)
Figure Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2017
Figure Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2016-2025) (K Units)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2018) (K Units)
Table Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2018)
Figure Central & South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2017
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries
Figure GCC Countries Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Type
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Application
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2017
Table GSK Company Details
Table GSK Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Teva Company Details
Table Teva Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table Cadila Company Details
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cadila Recent Development
Table Apotex Company Details
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Apotex Recent Development
Table Daewoong Pharmaceutical Company Details
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Daewoong Pharmaceutical Recent Development
Table Livzon Company Details
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Livzon Recent Development
Table Luoxin Company Details
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Luoxin Recent Development
Table Med shine Company Details
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Med shine Recent Development
Table Bayer (Campho Phenique) Company Details
Table Blistex Company Details
Table Kelun Group Company Details
Table Hikma Company Details
Table Haiwang Company Details
Table Carmex Company Details
Table Cipher Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Drugs for Herpes Labialis (Oral Herpes) Value Chain
Table Typical Suppliers of Key Drugs for Herpes Labialis (Oral Herpes) Raw Material
Table Drugs for Herpes Labialis (Oral Herpes) Customers List
Table Drugs for Herpes Labialis (Oral Herpes) Sales Channels
Table Drugs for Herpes Labialis (Oral Herpes) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *